Prioritizing deeper customer insights helps life sciences marketers understand how to engage their HCP audiences effectively ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses the company's nationwide push to reduce cardiovascular risk ...

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The ability to predict side effects such as nausea before starting treatment represents a paradigm shift in precision ...

Acquisition includes INZ-701, a late-stage enzyme replacement therapy targeting ectonucleotide ...

Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations.

PE: How can digital solutions address gaps in women’s healthcare? Partridge: Digital solutions play a crucial role in ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, explains why seamless communication and treatment continuity across ...

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or ...

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in ...

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.